Business Context and Reporting Period
Company: Progyny, Inc. (PGNY)
Filing Type: Form 8-K (Current Report)
Report Date: August 6, 2026
Reporting Period: Fiscal Quarter Ended June 30, 2026
This filing announces the release of financial results for the second quarter of 2026. The report incorporates a press release (Exhibit 99.1) and a supplemental earnings presentation (Exhibit 99.2) by reference.
Key Financial Metrics
The provided text serves as a cover document for the earnings announcement and does not contain specific numerical data. The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached exhibits for detailed financial figures.
Material Changes
No material changes or comparative financial data are disclosed within the body of this Form 8-K. The document solely confirms the issuance of the Q2 2026 results.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release and supplemental presentation containing management's discussion of results, but the text of this 8-K does not include specific commentary, guidance, or outlook statements.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Unusual Items: None reported in this summary document.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2026 revenue, net income, and cash flow figures.
- Examine Exhibit 99.2 (Supplemental Presentation) for segment performance, margin analysis, and forward-looking guidance.
- Verify the accuracy of the fiscal quarter end date (June 30, 2026) against the company's fiscal calendar.
- Check the investor relations website (investors.progyny.com) for the full supplemental presentation referenced in the filing.